Excell Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
- Satisfied Charges ₹ 1.35 M
- Revenue Growth 3.29%
- Profit Growth 90.36%
- Ebitda 85.65%
- Net Worth 18.75%
- Total Assets 10.22%
About Excell Formulations
Excell Formulations Private Limited (EFPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 April 1995 and has a history of 29 years and nine months. Its registered office is in Thane, Maharashtra.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹1.35 M, as per Ministry of Corporate Affairs (MCA) records.
Kausik Chakraborty, Bhaskar Chaudhuri, Hemant Hajare, and Two other members serve as directors at the Company.
Company Details
- LocationThane, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24230MH1995PTC087403
- Company No.
087403
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 1995
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Excell Formulations?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemant Hajare  | Director | 18-Apr-1995 | Current |
| Kausik Chakraborty | Director | 29-Jul-2011 | Current |
| Bhaskar Chaudhuri | Director | 29-Jul-2011 | Current |
| Ashok Singh | Director | 18-Apr-1995 | Current |
| Himanshu Kumar | Director | 19-Apr-1995 | Current |
Financial Performance of Excell Formulations.
Excell Formulations Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.29% increase. The company also saw a substantial improvement in profitability, with a 90.36% increase in profit. The company's net worth Soared by an impressive increase of 18.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Excell Formulations?
In 2023, Excell Formulations had a promoter holding of 91.00% and a public holding of 9.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Excellar Healthcare Private LimitedKausik Chakraborty, Bhaskar Chaudhuri and 3 more are mutual person
Pelfizz Biotech Private LimitedHemant Hajare and Ashok Singh are mutual person
Rohika Pharmaceuticals Private LimitedBhaskar Chaudhuri is a mutual person
- Perch Fisheries Llp
Hemant Hajare is a mutual person
- Varun Medico Lab Private Limited
Hemant Hajare is a mutual person
- Aahar Associates (India) Private Limited
Hemant Hajare and Ashok Singh are mutual person
Charges (Loans)
₹10.00 M
₹1.35 M
Charges Breakdown by Lending Institutions
- Punjab National Bank : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2015 | Punjab National Bank | ₹1.00 Cr | Open |
| 20 Aug 2009 | Axis Bank Limited | ₹1.35 M | Satisfied |
How Many Employees Work at Excell Formulations?
Unlock and access historical data on people associated with Excell Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Excell Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Excell Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
